Intelligence desk

Products

Signal Tracker Data Platform Data Enrichment API

Solutions

Deal Origination Executive Search For Sales Teams Corporate Development For Founders For Agencies For Investors Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Start Free
MyCellHub logo — Digital GMP workflows for streamlined manufacturing

MyCellHub

Digital GMP workflows for streamlined manufacturing

Founded 2019 Belgium Belgium 18 employees Acquired Total: $3.10M Analytics, Data Analytics +2

General Information

Company Name MyCellHub
Founded Year 2019
Location Belgium Belgium +2
Founders / Decision Makers
Sebastien de Bournonville — Co-founder and CBDO
Employees 18
Industries Analytics, Data Analytics, Manufacturing +1
Funding Stage Acquired
Social

Get notified when MyCellHub moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

AI Insight

Bounce Watch AI
1 month ago

MyCellHub was strategically acquired by Title21 in January 2026, marking a significant exit for its early investors and integrating its digital GMP workflow solutions into a larger ecosystem. This acquisition underscores the growing demand for streamlined, compliant manufacturing processes within the cell and gene therapy industry. The subsequent substantial website update in July 2026 strongly indicates active integration efforts and a strategic repositioning under its new ownership, likely to reflect expanded offerings or a unified brand presence.

Signal Types
Acquisition Product Update
Strategic Labels
Acquisition Integration Market Consolidation
Next Move: Integration
·
Impact: 9/10
·
Ideal For: Strategic Acquirers in Biotech SaaS

About MyCellHub

MyCellHub, founded in 2019, is a Belgium-based startup specializing in digitalizing and integrating data analytics in regulated laboratory and cleanroom workflows. With the slogan "Digital GMP workflows for streamlined manufacturing," the company directly addresses the inefficiencies of the biotech and (bio)pharmaceutical sectors, where over 90% of companies still utilize paper-based production reports. By digitizing these workflows, MyCellHub aims to expedite the launch of new therapies, reducing the industry's reliance on cumbersome paperwork.

The company operates primarily within the Analytics, Data Analytics, Manufacturing, and Telecom sectors. Their innovative approach has garnered attention, culminating in an acquisition investment from Title21 on 01 January 2026. As the demand for streamlined, efficient processes in the biotech and pharmaceutical fields continues to grow, MyCellHub is well-positioned to capitalize on the modernization of these industries.

Taxonomy: Digital GMP Workflows, Data Integration, Biotherapeutics Industry, Regulated Laboratory Processes, Cleanroom Workflows, SaaS Platform, Manufacturing Efficiency, Cell Culture Analytics, Real-Time Audit Trail, Automated Batch Records, Paperless Manufacturing, ERP Integration, Electronic Batch Record (EBR)

Services & Products

Cell and Gene Therapy Orchestration
Manufacturing Execution System
Enterprise Quality Management System
Blood and Marrow Transplant Services
GMP Facilities Services

Target Customers

Blood Centers Biobanks CAR-T Manufacturers Biotherapeutic Manufacturers Cellular Therapy Laboratories Standard of Care Facilities

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Acquisition Unknown 1 Title21 01 Jan 2026
Early VC €2.00M 2
The Faktory Fund
Gemma Frisius Fund - GFF 		01 Dec 2022
Seed €1.10M - 01 Sep 2019
Seed Unknown 1 Start it @KBC 01 May 2019
Spinout Unknown 1
KU Leuven Research & Development
01 Jan 2019

MyCellHub Alternatives & Competitors

View All Alternatives
MyCellHub vs
BigPicture.io
BigPicture.io United States

BigPicture provides company APIs for data-driven B2B teams.

3 employees
MyCellHub vs
SIMILIA AI
SIMILIA AI

Technological solutions for efficient data management and cost reduction.

MyCellHub vs
Fishbowl
Fishbowl United States

The industry’s most flexible inventory management solution

223 employees
Logistics, Manufacturing
View all alternatives

FAQ About MyCellHub

Digital GMP workflows for streamlined manufacturing
MyCellHub was founded in 2019.
MyCellHub is headquartered in Belgium.
MyCellHub operates in the following industries: Analytics, Data Analytics, Manufacturing, Telecom.
MyCellHub has approximately 18 employees.
MyCellHub has completed 5 funding rounds, raising a total of $3.10M. The latest funding stage is Acquired.
MyCellHub offers: Cell and Gene Therapy Orchestration, Manufacturing Execution System, Enterprise Quality Management System, Blood and Marrow Transplant Services, GMP Facilities Services.
Top alternatives and competitors to MyCellHub include BigPicture.io, SIMILIA AI, Fishbowl, GAGAT AM - 3D printing farm & AM service provider, naas.ai. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
MyCellHub and BigPicture.io are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors MyCellHub and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

Start Tracking — Free

One analytics cookie (Google Analytics). Cookie Policy